Bristol Myers Squibb (BMY) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Bristol myers Squibb Company  (NYSE: BMY)
 

Bristol Myers Squibb Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bristol Myers Squibb Company inventory turnover ratio, the Bristol Myers Squibb Company's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 5.24 in the first quarter 2026, BMY's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Bristol Myers Squibb in Mar 31 2026 quarter, has decreased to 70 days, compare to 71 days, in the Dec 31 2025 quarter.

Within Healthcare sector 71 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 133 in the fourth quarter 2025, to 263.

BMY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bristol Myers Squibb Company Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMY Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 3.38 % 5.2 % -17.23 % -11.05 % -10.69 %
Y / Y Cost of Sales Growth 12.79 % -14.88 % 16.17 % 3.21 % 3.44 %
Inventory Turnover Ratio (TTM) 5.24 5.14 5.47 5.02 4.84
BMY's Total Ranking # 263 # 133 # 200 # 225 # 85
Average inventory processing period 70 71 67 73 75
Seq. Inventory Growth 2.45 % -2.47 % 0.77 % 2.66 % 4.26 %
Seq. Cost of Sales Growth -16.48 % 19.24 % 1.87 % 11.18 % -36.97 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 72
Overall Market # 263

Inventory Turnover Ratio Statistics
High Average Low
5.89 3.86 2.44
(Sep 30 2019)   IV. Quarter



BMY Company Profile >> Back to BMY Efficiency Comparisons >> Compare BMY Inventory Turnover Ratio to its Competitors

Financial Statements
Bristol Myers Squibb's Inventories $ 2,756 Millions Visit BMY's Balance sheet
Bristol Myers Squibb's Cost of Revenues TTM $ 14,324 Millions Visit BMY's Income Statement
What are BMY's Sales? Visit BMY's Sales by Segment

Other Inventory Turnover Ratios
Bristol Myers Squibb's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BMY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BMY's Competitors
Inventory Turnover Ratio for BMY's Suppliers
Inventory Turnover Ratio for BMY's Customers

You may also want to know
BMY's Sales Growth Rates BMY's Pe Price to earnings ratio BMY's Receivables Turnover Ratio BMY's Stock Quote
BMY's Net Income Growth Rates BMY's Ps Price to Sales ratio BMY's Sales per Employee BMY's Asset Turnover Ratio
BMY's Net Margin BMY's Pb Price to Book ratio BMY's Financial Strength Ratios BMY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Aurinia Pharmaceuticals Inc   14.12 $ 30.596  Millions$ 2  Millions
Star Equity Holdings Inc   13.78 $ 106.877  Millions$ 8  Millions
Natera Inc   13.48 $ 869.958  Millions$ 65  Millions
Cryo cell International Inc   13.44 $ 7.049  Millions$ 1  Millions
The Oncology Institute Inc   11.17 $ 211.805  Millions$ 19  Millions
Genedx Holdings Corp   11.09 $ 135.000  Millions$ 12  Millions
Infusystem Holdings Inc  10.96 $ 61.593  Millions$ 6  Millions
Irhythm Holdings Inc   10.94 $ 228.000  Millions$ 21  Millions
Earth Science Tech Inc   10.81 $ 8.224  Millions$ 1  Millions
Option Care Health Inc   10.74 $ 4,579.720  Millions$ 427  Millions
Zevra Therapeutics Inc   10.44 $ 17.034  Millions$ 2  Millions
Alnylam Pharmaceuticals Inc   10.38 $ 814.503  Millions$ 78  Millions
Nutriband Inc   10.06 $ 1.291  Millions$ 0  Millions
Lantheus Holdings Inc   9.75 $ 610.000  Millions$ 63  Millions
Sotera Health Company  9.58 $ 531.000  Millions$ 55  Millions
Warby Parker Inc   9.23 $ 415.000  Millions$ 45  Millions
Tarsus Pharmaceuticals Inc   9.09 $ 37.864  Millions$ 4  Millions
National Vision Holdings Inc   8.90 $ 833.415  Millions$ 94  Millions
Myriad Genetics Inc   8.35 $ 248.000  Millions$ 30  Millions
Pulse Biosciences Inc   8.08 $ 0.909  Millions$ 0  Millions
Castle Biosciences Inc   7.97 $ 75.178  Millions$ 9  Millions
Moderna Inc   7.96 $ 1,733.000  Millions$ 218  Millions
Carlsmed Inc   7.95 $ 12.557  Millions$ 2  Millions
Inogen Inc   7.80 $ 195.741  Millions$ 25  Millions
Cardiff Lexington Corporation  7.70 $ 4.159  Millions$ 1  Millions
Novavax inc   7.67 $ 89.620  Millions$ 12  Millions
Prophase Labs Inc   7.64 $ 2.361  Millions$ 0  Millions
Bellevue Life Sciences Acquisition Corp  7.62 $ 1.986  Millions$ 0  Millions
Lifemd Inc   7.60 $ 24.000  Millions$ 3  Millions
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions

Date modified: 2026-07-06T19:32:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.